Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	20.89	-19.77	-24.99
Graham Fair Price	41.42	1.46	1.03
PEG	-100.00	< 0.005	0.00
Price/Book	-31.82	0.25	0.37
Price/Cash Flow	12.88	-21.73	-24.94
Prices/Earnings	65.91	-0.95	-2.80
Price/Sales	-54.95	10.52	23.36
Price/FCF	12.88	-21.73	-24.94
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-43.14	0.24	0.43
Operating Margin	10.73	-1.04	-1.17
ROA	-100.00	-0.06	-0.03
ROE	-0.03	-0.07	-100.00
ROIC	-0.02	-0.02	-34.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.09	-0.83	-88.59
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-0.35	-100.00
EPS QOQ	0.00	-1.00	-100.00
FCF QOQ	0.00	0.22	100.00
Revenue QOQ	0.00	0.51	100.00
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.55	0.28	-50.00
Days Sales Outstanding (DSO)	47.38	135.37	185.71
Inventory Turnover	162.82	325.64	100.00
Debt/Capitalization	0.07	0.08	8.71
Quick Ratio	0.35	0.58	65.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.20	1.20	< 0.005
Cash	0.04	0.04	< 0.005
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	-0.02	-0.01	21.74
Revenue	0.02	0.03	51.35
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.58	0.58	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.07	-3.75	-22.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating